Korea/Asia, Events, IPOs, Douglas Research Advisory

Douglas Kim

Korea/Asia, Events, IPOs

Thematic (Sector/Industry)

<ul><li><div class="content-highlight">In this report, we have identified more than 40 stocks in the Korean stock market that have announced share buyback programs in the past four months. Many of these stocks that have been buying back their shares have been outperforming the market in recent weeks. Share buybacks continue to be an <em>"alpha generating"</em> catalyst in the Korean stock market. Time and again, companies that buyback stocks in Korea tend to outperform the market.</div></li></ul><ul><li><p>In terms of size, the share buyback announcement by Samsung…</p></li></ul>

In this report, we have identified more than 40 stocks in the Korean stock market that have announced share buyback programs in the past four months. Many of these stocks that have been buying back their shares have been outperforming the market in recent weeks. Share buybacks continue to be an "alpha generating" catalyst in the Korean stock market. Time and again, companies that buyback stocks in Korea tend to outperform the market.In terms of size, the share buyback announcement by Samsung…

Alpha Generation from Share Buybacks in Korea (August - November 2017)

Korea / Special Sits, Pairs, Index Rebalancing, Clepsydra Capital

Sanghyun Park

Korea / Special Sits, Pairs, Index Rebalancing

<p>As I said in my earlier comment, <a href="https://www.smartkarma.com/entities/22932" target="_blank" data-smartkarma-citation="entities:22932:1">Samsung Biologics Co., Ltd (207940 KS)</a> seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps because of this, I am receiving some inquiries about who will be included and excluded in the upcoming reshuffle of KOSPI200 and KOSDAQ150. The decisions were already made and confirmed on May 16, and the changes will be officially made on June 9. But I guess many of us here on Smartkarma community wants a "concise" summary of this reshuffle. So, I…</p>

As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps because of this, I am receiving some inquiries about who will be included and excluded in the upcoming reshuffle of KOSPI200 and KOSDAQ150. The decisions were already made and confirmed on May 16, and the changes will be officially made on June 9. But I guess many of us here on Smartkarma community wants a "concise" summary of this reshuffle. So, I…

Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle

South Korea

Kukdo Chemical Co. Ltd. manufactures and sells organic chemicals, such as epoxy resins and hydro sulfuric acid.  The Company also produces inorganic chemicals used in antiseptics, bleaches, and sterilizers.

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Kukdo Chemical (007690 KS)

Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle

As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...

Sanghyun Park

Price Gauge

52-week Range

Market Cap (USDm)

P/E

Dividend (Yield)

Alpha Generation from Share Buybacks in Korea (August - November 2017)

In this report, we have identified more than 40 stocks in the Korean stock market that have announced share buyback programs in the past four...

Douglas Kim

Summary of KOSPI200 & KOSDAQ150 Upcoming Reshuffle

As I said in my earlier comment, Samsung Biologics Co., Ltd (207940 KS) seems to be benefiting a lot from its inclusion in KOSPI200 index. Perhaps...

Sanghyun Park